# Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM)

> **NCT04962711** · NA · RECRUITING · sponsor: **Baker Heart and Diabetes Institute** · enrollment: 685 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **OTHER:** Heart Failure intervention (Cardio-Oncology Disease Management Plan (CO-DMP)
- **OTHER:** Usual care

## Key facts

- **NCT ID:** NCT04962711
- **Lead sponsor:** Baker Heart and Diabetes Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-30
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 685 (ESTIMATED)
- **Last updated:** 2025-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04962711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04962711, "Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04962711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*